tiprankstipranks

Kathryn Falberg Insider Profile

18 Followers
Kathryn Falberg, Director at Halozyme, holds 146.91K shares in Trade Desk (Ticker: TTD), holds 157.41K shares in Arcus Biosciences (Ticker: RCUS), holds 250.00K shares in Nuvation Bio (Ticker: NUVB). Most recently, Kathryn Falberg Sold ― shares of Trade Desk on Aug 15, 2024 for an estimated value of 14.73M.
tipranks
Kathryn Falberg

Kathryn Falberg
Halozyme (HALO)
Director

Ranked #10,814 out of 99,335 Corporate Insiders

Profitable Transactions

44%
7 out of 16 Profitable Transactions

Average Return

+11.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$54M
34.66%
30.91%
28.62%
4.16%
1.64% Others
A breakdown of Kathryn Falberg's holdings

Insider Roles

Trade Desk
(TTD)
Director
Jazz Pharmaceuticals
(JAZZ)
EVP & CFO
Halozyme
(HALO)
Director
Arcus Biosciences
(RCUS)
Director
+4 other positions
Roles that Kathryn Falberg holds in companies

Most Profitable Insider Trade

Stock:
Arcus Biosciences
(RCUS)
Rating:Informative Buy
Date:Jun 11, 2019 - Jun 11, 2020
Return:+254.00%
The most profitable trade made by Kathryn Falberg

Kathryn Falberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Halozyme
May 06, 2016
Director
Uninformative Buy
$15.45M
AIMT
Aimmune Therapeutics
Oct 14, 2020
Uninformative Sell
270.48K
$0.00
BioMarin Pharmaceutical
Jul 19, 2016
Director
Uninformative Buy
$209.38K
SIOX
Sio Gene Therapies
Apr 19, 2017
Informative Buy
999.99K
$0.00
Trade Desk
Aug 15, 2024
Director
Informative Sell
14.73M
$18.71M
TCDAQ
Tricida
Jun 11, 2021
Uninformative Buy
$591.63
Urogen Pharma
Director
Arcus Biosciences
Jun 07, 2024
Director
Uninformative Buy
$2.25M
Nuvation Bio
Dec 05, 2022
Director
Informative Buy
483.11K
$675.00K
MDVN
Medivation
Sep 30, 2016
Uninformative Sell
$3.22M
Jazz Pharmaceuticals
Mar 06, 2014
EVP & CFO
Uninformative Sell
242.39K
$16.69M
Oruka Therapeutics
Jun 17, 2009
CFO and COO
Informative Sell
7.88K
$0.00
NVLNF
Novelion Therapeutics
$0.00
List of latest transactions for each holding click on a transaction to see Kathryn Falberg's performance on stock

Kathryn Falberg insider profile FAQ

What is the percentage of profitable transactions made by Kathryn Falberg?
The percentage of profitable transactions made by Kathryn Falberg is 44%.
    What is the average return per transaction made by Kathryn Falberg?
    The average return per transaction made by Kathryn Falberg is 11.90%.
      What stocks does Kathryn Falberg hold?
      Kathryn Falberg holds: HALO, AIMT, BMRN, SIOX, TTD, TCDAQ, URGN, RCUS, NUVB, MDVN, JAZZ, ORKA, NVLNF stocks.
        What was Kathryn Falberg’s latest transaction?
        Kathryn Falberg latest transaction was an Informative Sell of $14.73M.
          What was Kathryn Falberg's most profitable transaction?
          Kathryn Falberg’s most profitable transaction was an Informative Buy of RCUS stock on June 11, 2019. The return on the trade was 254.00%.
            What is Kathryn Falberg's role in Halozyme?
            Kathryn Falberg's role in Halozyme is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.